Nabriva Therapeutics (NBRV) SEC Filings & 10K Form

Recent Nabriva Therapeutics SEC Filings

DateFilerForm TypeView
10/25/2023
12:43 PM
Nabriva Therapeutics (Filer)
Form 15-12G
10/24/2023
11:15 PM
Nabriva Therapeutics (Filer)
Form EFFECT
10/19/2023
7:14 PM
Nabriva Therapeutics (Filer)
Form S-8 POS
10/19/2023
7:16 PM
Nabriva Therapeutics (Filer)
Form S-8 POS
10/19/2023
7:17 PM
Nabriva Therapeutics (Filer)
Form S-8 POS
10/19/2023
7:19 PM
Nabriva Therapeutics (Filer)
Form S-8 POS
10/19/2023
7:20 PM
Nabriva Therapeutics (Filer)
Form S-8 POS
10/19/2023
7:22 PM
Nabriva Therapeutics (Filer)
Form S-8 POS
10/19/2023
7:23 PM
Nabriva Therapeutics (Filer)
Form S-8 POS
10/19/2023
7:25 PM
Nabriva Therapeutics (Filer)
Form S-8 POS
10/19/2023
8:01 PM
Nabriva Therapeutics (Filer)
Form POS AM
09/08/2023
9:11 AM
Nabriva Therapeutics (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
07/31/2023
7:07 AM
Nabriva Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
8:00 AM
Nabriva Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
4:51 PM
HOGAN H MICHAEL III (Reporting)
Nabriva Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2023
4:49 PM
Maggio David (Reporting)
Nabriva Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NBRV) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners